---
figid: PMC7672569__ijerph-17-07825-g002
figlink: pmc/articles/PMC7672569/figure/ijerph-17-07825-f002/
number: F2
caption: 'Targeted signalling pathway involved in endothelial cells (ECs) activation
  and vascular smooth muscle cells (VSMCs) proliferation and migration during intimal
  hyperplasia. The binding of vascular endothelial growth factor A (VEGFA) to its
  receptor VEGFR2 on ECs activates the PI3K pathway. Activated PDK1 phosphorylates
  Akt at Thr308 then phosphorylates eNOS at Ser1177 activating eNOS. VEGFA aslo activates
  the PLCγ pathway which increase Ca2+ concentration and activates eNOS via calmodulin
  (CaM). The binding of VEGFA also activates Src kinase which then activates eNOS
  through two mechanisms: (1) phosphorylation of Tyr83 on eNOS; (2) phosphorylation
  of heat shock protein 90 (HSP90) at Tyr300. Those phosphorylation causes the binding
  of HSP90 to eNOS and activates NO synthesis. Activated eNOS converts L-arginine
  in the presence of oxygen to L-citrulline and diffusible signalling molecule NO.
  NO secreted by ECs inhibits platelet aggregation to avoid thrombosis. NO diffuses
  into vessel walls, causing arterial vessels to relax and increase blood flow. The
  binding of agonist to G-protein–coupled receptors (GPCR) induces activation of Rho-kinase
  activity via GEF activation. The activity of RhoA is controlled by the guanine nucleotide
  exchange factors (GEFs) that catalyse the exchange of GDP for GTP. Rho-kinase activity
  is enhanced by binding to the active GTP-bound RhoA. However, this mechanism is
  negatively regulating eNOS activation for NO production. Diffused NO binds to its
  intracellular receptor soluble GC (sGC) which produces cGMP from GTP. The increase
  in intracellular cGMP concentration bind to cGMP-dependent protein kinases (PKGs)
  and cGMP-gated ion channels results the increase of Ca2+ and relaxation of smooth
  muscle.'
pmcid: PMC7672569
papertitle: 'The Effects of Pro-Inflammatory and Anti-Inflammatory Agents for the
  Suppression of Intimal Hyperplasia: An Evidence-Based Review.'
reftext: Rohaina Che Man, et al. Int J Environ Res Public Health. 2020 Nov;17(21):7825.
pmc_ranked_result_index: '45065'
pathway_score: 0.9766728
filename: ijerph-17-07825-g002.jpg
figtitle: Targeted signalling pathway involved in endothelial cells (ECs) activation
  and vascular smooth muscle cells (VSMCs) proliferation and migration during intimal
  hyperplasia
year: '2020'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7672569__ijerph-17-07825-g002.html
  '@type': Dataset
  description: 'Targeted signalling pathway involved in endothelial cells (ECs) activation
    and vascular smooth muscle cells (VSMCs) proliferation and migration during intimal
    hyperplasia. The binding of vascular endothelial growth factor A (VEGFA) to its
    receptor VEGFR2 on ECs activates the PI3K pathway. Activated PDK1 phosphorylates
    Akt at Thr308 then phosphorylates eNOS at Ser1177 activating eNOS. VEGFA aslo
    activates the PLCγ pathway which increase Ca2+ concentration and activates eNOS
    via calmodulin (CaM). The binding of VEGFA also activates Src kinase which then
    activates eNOS through two mechanisms: (1) phosphorylation of Tyr83 on eNOS; (2)
    phosphorylation of heat shock protein 90 (HSP90) at Tyr300. Those phosphorylation
    causes the binding of HSP90 to eNOS and activates NO synthesis. Activated eNOS
    converts L-arginine in the presence of oxygen to L-citrulline and diffusible signalling
    molecule NO. NO secreted by ECs inhibits platelet aggregation to avoid thrombosis.
    NO diffuses into vessel walls, causing arterial vessels to relax and increase
    blood flow. The binding of agonist to G-protein–coupled receptors (GPCR) induces
    activation of Rho-kinase activity via GEF activation. The activity of RhoA is
    controlled by the guanine nucleotide exchange factors (GEFs) that catalyse the
    exchange of GDP for GTP. Rho-kinase activity is enhanced by binding to the active
    GTP-bound RhoA. However, this mechanism is negatively regulating eNOS activation
    for NO production. Diffused NO binds to its intracellular receptor soluble GC
    (sGC) which produces cGMP from GTP. The increase in intracellular cGMP concentration
    bind to cGMP-dependent protein kinases (PKGs) and cGMP-gated ion channels results
    the increase of Ca2+ and relaxation of smooth muscle.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - VEGFA
  - TNF
  - FLT1
  - FLT4
  - KDR
  - SRC
  - PIK3CA
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R6
  - PLCG1
  - PLCG2
  - SLC2A4RG
  - PDK1
  - RHOA
  - KRIT1
  - AKT2
  - AKT3
  - AKT1
  - NOS3
  - ARHGEF12
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - SGCB
  - COX4I1
  - COX6A1
  - COX6A2
  - COX6B1
  - COX7A1
  - COX7A2
  - COX8A
  - COX10
  - COX11
  - COX5A
  - COX17
  - COX4I2
  - COX8C
  - COX5B
  - COX7B
  - COX15
  - COX6B2
  - COX7B2
  - PGR
  - CA1
  - NFKB1
  - NFKB2
  - REL
  - RELA
  - RELB
  - PRKG1
  - 5-HT
  - 'NO'
  - Ca
  - Arg
  - CGMP
  - ATP
  - platelet aggregation
genes:
- word: VEGFA
  symbol: VEGFA
  source: hgnc_symbol
  hgnc_symbol: VEGFA
  entrez: '7422'
- word: TNFA,
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: TNFA,Angll,5-HT,ET-1,
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT1
  entrez: '2321'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: FLT4
  entrez: '2324'
- word: VEGFR
  symbol: VEGFR
  source: bioentities_symbol
  hgnc_symbol: KDR
  entrez: '3791'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG1
  entrez: '5335'
- word: PLCY
  symbol: PLCG
  source: bioentities_symbol
  hgnc_symbol: PLCG2
  entrez: '5336'
- word: GEF
  symbol: GEF
  source: hgnc_alias_symbol
  hgnc_symbol: SLC2A4RG
  entrez: '56731'
- word: PDK1
  symbol: PDK1
  source: hgnc_symbol
  hgnc_symbol: PDK1
  entrez: '5163'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: RhoA
  symbol: RhoA
  source: hgnc_alias_symbol
  hgnc_symbol: RHOA
  entrez: '387'
- word: CaM
  symbol: CAM
  source: hgnc_alias_symbol
  hgnc_symbol: KRIT1
  entrez: '889'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: eNOS
  symbol: eNOS
  source: hgnc_alias_symbol
  hgnc_symbol: NOS3
  entrez: '4846'
- word: Src
  symbol: SRC
  source: hgnc_symbol
  hgnc_symbol: SRC
  entrez: '6714'
- word: L-Arg
  symbol: LARG
  source: hgnc_alias_symbol
  hgnc_symbol: ARHGEF12
  entrez: '23365'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: SGC
  symbol: SGC
  source: hgnc_alias_symbol
  hgnc_symbol: SGCB
  entrez: '6443'
- word: L-Arg
  symbol: LARG
  source: hgnc_alias_symbol
  hgnc_symbol: ARHGEF12
  entrez: '23365'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I1
  entrez: '1327'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A1
  entrez: '1337'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6A2
  entrez: '1339'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B1
  entrez: '1340'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A1
  entrez: '1346'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7A2
  entrez: '1347'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8A
  entrez: '1351'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX10
  entrez: '1352'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX11
  entrez: '1353'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5A
  entrez: '9377'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX17
  entrez: '10063'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX4I2
  entrez: '84701'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX8C
  entrez: '341947'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX5B
  entrez: '1329'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B
  entrez: '1349'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX15
  entrez: '1355'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX6B2
  entrez: '125965'
- word: COX
  symbol: COX
  source: bioentities_symbol
  hgnc_symbol: COX7B2
  entrez: '170712'
- word: PGI,R
  symbol: PGR
  source: hgnc_symbol
  hgnc_symbol: PGR
  entrez: '5241'
- word: TNFA
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
- word: Cal
  symbol: CA1
  source: hgnc_symbol
  hgnc_symbol: CA1
  entrez: '759'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: SGC
  symbol: SGC
  source: hgnc_alias_symbol
  hgnc_symbol: SGCB
  entrez: '6443'
- word: PKG
  symbol: PKG
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: Cal
  symbol: CA1
  source: hgnc_symbol
  hgnc_symbol: CA1
  entrez: '759'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB1
  entrez: '4790'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: NFKB2
  entrez: '4791'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: REL
  entrez: '5966'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELA
  entrez: '5970'
- word: NFKB
  symbol: NFKB
  source: bioentities_symbol
  hgnc_symbol: RELB
  entrez: '5971'
- word: TNFa
  symbol: TNFA
  source: hgnc_prev_symbol
  hgnc_symbol: TNF
  entrez: '7124'
chemicals:
- word: 5-HT
  source: MESH
  identifier: D012701
- word: 'NO'
  source: ''
  identifier: ''
- word: Ca
  source: MESH
  identifier: D002118
- word: Arg
  source: MESH
  identifier: C076685
- word: CGMP
  source: MESH
  identifier: C016276
- word: ATP
  source: MESH
  identifier: D000255
diseases:
- word: platelet aggregation
  source: MESH
  identifier: D001791
figid_alias: PMC7672569__F2
redirect_from: /figures/PMC7672569__F2
figtype: Figure
---
